Published on in Vol 14, No 1 (2022): Jan-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/32125, first published .
Implementing the Co-Immune Open Innovation Program to Address Vaccination Hesitancy and Access to Vaccines: Retrospective Study

Implementing the Co-Immune Open Innovation Program to Address Vaccination Hesitancy and Access to Vaccines: Retrospective Study

Implementing the Co-Immune Open Innovation Program to Address Vaccination Hesitancy and Access to Vaccines: Retrospective Study

Camille Masselot   1 * , MPH ;   Bastian Greshake Tzovaras   2 * , PhD ;   Chris L B Graham   1 , MSc ;   Gary Finnegan   3 , MSc ;   Rathin Jeyaram   2 , MSc ;   Isabelle Vitali   4 , MBA ;   Thomas Landrain   1 , MSc ;   Marc Santolini   1, 2 , PhD

1 Just One Giant Lab Association, Paris, France

2 Center for Research and Interdisciplinarity, INSERM U1284, Universite de Paris, Paris, France

3 IXL Editorial, Kildare, Ireland

4 Sanofi, Gentilly, France

*these authors contributed equally

Corresponding Author:

  • Marc Santolini, PhD
  • Center for Research and Interdisciplinarity
  • INSERM U1284
  • Universite de Paris
  • 8bis rue Charles V
  • Paris, F-75006
  • France
  • Phone: 33 679751700
  • Fax: 33 632377297
  • Email: marc.santolini@cri-paris.org